BSEShelter Pharma LtdMediumPositive
Announced Tue, 2 Jun · 14:40 IST

Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- Receipt of Renewal Manufacturing Licence

Regulatory Product ApprovalBusiness Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹31.99
prior close
₹31.98
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-1.5-1.5-5.8-8.5-6.3-5.9-8.6-8.4
Up moveDown movePending
AI summary

Shelter Pharma Limited has received a renewal of its Manufacturing Licence (Form 25D) from the Food & Drugs Control Administration (Ayurved), Government of Gujarat. The licence covers the manufacture and sale of Ayurvedic, Siddha and Unani Drugs at the company's facility in Himatnagar, Gujarat. The renewed licence is valid until September 2030, subject to compliance with applicable regulatory requirements. The company states that the renewal allows uninterrupted continuation of manufacturing operations and reinforces its regulatory compliance framework. Management views this as a foundation for sustained growth in the Ayurvedic healthcare segment.

Likely market impact

Positive but routine — the licence renewal ensures business continuity for the company's Ayurvedic manufacturing operations through 2030, with no immediate material impact on financials expected.